Your browser doesn't support javascript.
loading
Long-term Lower Extremity and Cardiovascular Complications after Simultaneous Pancreas-Kidney Transplant.
Amara, Dominic; Braun, Hillary J; Shui, Amy M; Sorrentino, Thomas; Ramirez, Joel L; Lin, Joseph; Liu, Iris H; Mello, Anna; Stock, Peter G; Hiramoto, Jade S.
Affiliation
  • Amara D; School of Medicine, University of California, San Francisco, CA, USA.
  • Braun HJ; Department of Surgery, University of California, San Francisco, CA, USA.
  • Shui AM; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
  • Sorrentino T; Department of Surgery, University of California, San Francisco, CA, USA.
  • Ramirez JL; Department of Surgery, University of California, San Francisco, CA, USA.
  • Lin J; Department of Surgery, University of California, San Francisco, CA, USA.
  • Liu IH; School of Medicine, University of California, San Francisco, CA, USA.
  • Mello A; Department of Surgery, University of California, San Francisco, CA, USA.
  • Stock PG; Department of Surgery, University of California, San Francisco, CA, USA.
  • Hiramoto JS; Department of Surgery, University of California, San Francisco, CA, USA.
Clin Transplant ; 35(3): e14195, 2021 03.
Article de En | MEDLINE | ID: mdl-33340143
ABSTRACT
Lower extremity (LE) vascular disease and adverse cardiovascular events (ACEs) cause significant long-term morbidity after simultaneous pancreas-kidney (SPK) transplantation. This study's purpose was to describe the incidence of, and risk factors associated with, LE vascular complications and related ACEs following SPK. All SPKs performed at the authors' institution from 2000 to 2019 were retrospectively analyzed. The primary outcome was any LE vascular event, defined as LE endovascular intervention, open surgery, amputation, or invasive podiatry intervention. Secondary outcomes included post-SPK ACE. A total of 363 patients were included, of whom 54 (14.9%) required at least one LE vascular intervention following SPK. Only 3 patients received pre-SPK ankle brachial indices (ABIs). A history of peripheral artery disease (PAD) (HR 2.95, CI 1.4-6.2) was a risk factor for post-SPK LE vascular intervention even after adjustment for other factors. Fifty-nine (16.3%) patients experienced an ACE in follow-up. Requiring a LE intervention post-SPK was associated with a subsequent ACE (HR 2.3, CI 1.2-4.5). LE vascular and cardiovascular complications continue to be significant sources of morbidity for SPK patients, especially for patients with preexisting PAD. The highest risk patients may benefit from more intensive pre- and post-SPK workup with ABIs and follow-up with a vascular surgeon.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transplantation rénale / Transplantation pancréatique / Diabète de type 1 Type d'étude: Observational_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Clin Transplant Sujet du journal: TRANSPLANTE Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transplantation rénale / Transplantation pancréatique / Diabète de type 1 Type d'étude: Observational_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Clin Transplant Sujet du journal: TRANSPLANTE Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique